Erratum to: Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice. Am J Physiol Heart Circ Physiol 292: H2202–H2211, 2007; doi:10.1152/ajpheart.00382.2006;Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 5, 2007, Pages H963-

  Werdich, Andreas A ^c   Baudenbacher, Franz ^c   Dzhura, Igor ^c   Jeyakumar, Loice H ^b   Kannankeril, Prince J ^a   Fleischer, Sidney ^d   LeGrone, Alison ^a   Milatovic, Dejan ^a   Aschner, Michael ^a   Strauss, Arnold W ^a   Anderson, Mark E ^e   Exil, Vernat J ^a,f  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

Calcium ion; Genetics; Inborn errors; Ryanodine receptor; Ventricular tachycardia

Indexed keywords

CAFFEINE; CALCIUM ION; CALSEQUESTRIN; ISOPRENALINE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; PHOSPHOLAMBAN; RYANODINE RECEPTOR 2; SODIUM; CALCIUM;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL LEVEL; CONTROLLED STUDY; FEMALE; FLUORESCENCE; GENOTYPE; HEART MUSCLE CELL; MALE; MICROSOME; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; SARCOMERE LENGTH; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE; VOLTAGE CLAMP; ANIMAL; CALCIUM SIGNALING; GENETICS; HEART VENTRICLE; HEART VENTRICLE TACHYCARDIA; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY;

ACYL-COA DEHYDROGENASE, LONG-CHAIN; ANIMALS; CALCIUM; CALCIUM SIGNALING; FEMALE; HEART VENTRICLES; MALE; MICE; MICE, KNOCKOUT; TACHYCARDIA, VENTRICULAR;

EID: 34250803188     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00382.2006     Document Type: Erratum

References (54)

1. 2+ current in rabbit ventricular myocytes. Circ Res 75: 854-861, 1994.
2. Arkin IT, Adams PD, MacKenzie KR, Lemmon MA, Brunger AT, Engelman DM. Structural organization of the pentameric transmembrane alpha-helices of phospholamban, a cardiac ion channel. EMBO J 13: 4757-4764, 1994.
3. Asahi M, Kimura Y, Kurzydlowski K, Tada M, MacLennan DH. Transmembrane helix M6 in sarco(endo)plasmic reticulum Ca(2+)-ATPase forms a functional interaction site with phospholamban. Evidence for physical interactions at other sites. J Biol Chem 274: 32855-32862, 1999.
4. Bassani JWM, Bassani RA, Bers DM. Calibration of indo-1 and resting intracellular [Ca](I) in intact rabbit cardiac myocytes. Biophys J 68: 1453-1460, 1995.
5. Berlin JR, Bassani JW, Bers DM. Intrinsic cytosolic calcium buffering properties of single rat cardiac myocytes. Biophys J 67: 1775-1787, 1994.
6. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Norwell, MA: Kluwer Academic, 2001.
7. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
8. i. Am J Physiol Cell Physiol 268: C271-C277, 1995.
9. Bers DM, Lederer WJ, Berlin JR. Intracellular Ca-transients in rat cardiac myocytes: role of Na-Ca exchange in excitation-contraction coupling. Am J Physiol Cell Physiol 258: C944-C954, 1990.
10. Blatter LA, Wier WG. Intracellular diffusion, binding, and compartmentalization of the fluorescent calcium indicators indo-1 and fura-2. Biophys J 58: 1491-1499, 1990.
11. Chamberlain BK, Fleischer S. Isolation of canine cardiac sarcoplasmic reticulum. Methods Enzymol 157: 91-99, 1988.
12. i. Circ Res 78: 857-862, 1996.
13. Dzhura I, Wu YJ, Colbran RJ, Balser JR, Anderson ME. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol 2: 173-177, 2000.
14. Exil VJ, Gardner CD, Rottman JN, Sims H, Bartelds B, Khuchua Z, Sindhal R, Ni G, Strauss AW. Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. Am J Physiol Heart Circ Physiol 290: H1289-H1297, 2006.
15. Exil VJ, Roberts RL, Sims H, McLaughlin JE, Malkin RA, Gardner CD, Ni G, Rottman JN, Strauss AW. Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. Circ Res 93: 448-455, 2003.
16. Exil VJ, Summar M, Boles MA, Atkinson J, Johns JA, Matern D, Strauss AW, Canter CE. Metabolic basis of pediatric heart disease. Prog Pediatr Cardiol 20: 143-159, 2005.
17. Field ML, Azzawi A, Unitt JF, Seymour AM, Henderson C, Radda GK. Intracellular [Ca2+] staircase in the isovolumic pressure: frequency relationship of Langendorff-perfused rat heart. J Mol Cell Cardiol 28: 65-77, 1996.
18. Francis J, Sankar V, Nair VK, Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2: 550-554, 2005.
19. Gao WD, Perez NG, Marban E. Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol 507: 175-184, 1998.
20. Griffiths EJ, Stern MD, Silverman HS. Measurement of mitochondrial calcium in single living cardiomyocytes by selective removal of cytosolic indo 1. Am J Physiol Cell Physiol 273: C37-C44, 1997.
21. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
22. Hale DE, Bennett MJ. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr 121: 1-11, 1992.
23. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85-100, 1981.
24. Haworth RA, Redon D. Calibration of intracellular Ca transients of isolated adult heart cells labelled with fura-2 by acetoxymethyl ester loading. Cell Cal 24: 263-273, 1998.
25. Hughes G, Starling AP, Sharma RP, East JM, Lee AG. An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban. Biochem J 318: 973-979, 1996.
26. James P, Inui M, Tada M, Chiesi M, Carafoli E. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature 342: 90-92, 1989.
27. Jeyakumar LH, Gleaves LA, Ridley BD, Chang P, Atkinson J, Barnett JV, Fleischer S. The skeletal muscle ryanodine receptor isoform 1 is found at the intercalated discs in human and mouse hearts. J Muscle Res Cell Motil 23: 285-292, 2002.
28. Kovacs RJ, Nelson MT, Simmerman HK, Jones LR. Phospholamban forms Ca2+-selective channels in lipid bilayers. J Biol Chem 263: 18364-18368, 1988.
29. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, Lorber A, Kastner DL, Goldman B, Pras E. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 103: 2822-2827, 2001.
30. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103: 485-490, 2001.
31. Lokuta AJ, Rogers TB, Lederer WJ, Valdivia HH. Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation- dephosphorylation mechanism. J Physiol Lond 487: 609-622, 1995.
32. Maier LS, Zhang T, Chen L, DeSantiago J, Brown JH, Bers DM. Transgenic CaMKII delta(C) overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res 92: 904-911, 2003.
33. Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol 33: 615-624, 2001.
34. Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol 190: 1-6, 2002.
35. Mathur A, Sims HF, Gopalakrishnan D, Gibson B, Rinaldo P, Vockley J, Hug G, Strauss AW. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation 99: 1337-1343, 1999.
36. Meissner G, el-Hashem A. Ryanodine as a functional probe of the skeletal muscle sarcoplasmic reticulum Ca2+ release channel. Mol Cell Biochem 114: 119-123, 1992.
37. 2+ concentration in living single rat cardiac myocytes. Am J Physiol Heart Circ Physiol 261: H1123-H1134, 1991.
38. Mohler PJ, Splawski I, Napolitano C, Bottelli G, Sharpe L, Timothy K, Priori SG, Keating MT, Bennett V. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci USA 101: 9137-9142, 2004.
39. Nof E, Lahat H, Constantini N, Luria D, Rosenfeld G, Eldar M, Pras E, Glikson M. A novel form of familial bidirectional ventricular tachycardia. Am J Cardiol 93: 231-234, 2004.
40. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103: 196-200, 2001.
41. Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet 4: 2151-2154, 1995.
42. Roe CR, Ding J. Mitochondrial fatty acid oxidation disorders. In: The Metbolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2002, p. 2297-2327.
43. Sambrano GR, Fraser I, Han H, Ni Y, O'Connell T, Yan Z, Stull JT. Navigating the signalling network in mouse cardiac myocytes. Nature 420: 712-714, 2002.
44. Simmerman HK, Collins JH, Theibert JL, Wegener AD, Jones LR. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J Biol Chem 261: 13333-13341, 1986.
45. Simmerman HK, Kobayashi YM, Autry JM, Jones LR. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J Biol Chem 271: 5941-5946, 1996.
46. Stokes DL, Pomfret AJ, Rice WJ, Glaves JP, Young HS. Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals. Biophys J 90: 4213-4223, 2006.
47. Strauss AW, Powell CK, Hale DE, Anderson MM, Ahuja A, Brackett JC, Sims HF. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. Proc Natl Acad Sci USA 92: 10496-10500, 1995.
48. Suda N, Kokubun S. The effect of extracellular Ca2+ concentration on the negative staircase of Ca2+ transient in field-stimulated rat ventricular cells. Pflugers Arch 429: 7-13, 1994.
49. Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, Kere J, Keto P, Kontula K, Toivonen L. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 34: 2035-2042, 1999.
50. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10: 189-194, 2001.
51. Valdivia HH, Fuentes O, el-Hayek R, Morrissette J, Coronado R. Activation of the ryanodine receptor Ca2+ release channel of sarcoplasmic reticulum by a novel scorpion venom. J Biol Chem 266: 19135-19138, 1991.
52. Zahradnikova A, Zahradnik I, Gyorke I, Gyorke S. Rapid activation of the cardiac ryanodine receptor by submillisecond calcium stimuli. J Gen Physiol 114: 787-798, 1999.
53. Zhai J, Schmidt AG, Hoit BD, Kimura Y, MacLennan DH, Kranias EG. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 275: 10538-10544, 2000.
54. Zhou Z, Matlib MA, Bers DM. Cytosolic and mitochondrial Ca2+ signals in patch clamped mammalian ventricular myocytes. J Physiol 507: 379-403, 1998.